131I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma

被引:2
|
作者
Castro, Gabriel [1 ]
Berrocal, Isabel [1 ]
Carmona, Jaime [1 ]
Gonzalez, Javiera [1 ]
Gonzalez, Patricio [1 ]
机构
[1] Univ Chile, Clin Hosp, Nucl Med Sect, Independencia, Santiago De Chi, Chile
关键词
Omeprazole; Differentiate Thyroid Cancer; Differentiate Thyroid Carcinoma; Radioiodine Therapy; Visual Score;
D O I
10.1007/s00259-012-2104-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:1356 / 1357
页数:2
相关论文
共 50 条
  • [21] 131I imaging in the therapy of differentiated thyroid cancer
    Vija, L. -M.
    Toubert, M. -E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (01): : 44 - 51
  • [22] Predictors of success of the ablative/therapeutic radioiodine (131I) in differentiated thyroid cancer
    Fard-Esfahani, Armaghan
    Valipouri, Mohammad Reza
    Harsini, Sara
    Beiki, Davood
    Emami-Ardekani, Alireza
    Fallahi, Babak
    Eftekhari, Mohammad
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2020, 28 (01): : 14 - 20
  • [23] 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma
    Toubeau, M
    Touzery, C
    Berriolo-Riedinger, A
    Cochet, A
    Brunotte, F
    Bedenne, L
    Cercueil, JP
    Krause, D
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (05) : 669 - 670
  • [24] Impact of thyroiditis on 131I uptake during ablative therapy for differentiated thyroid cancer
    Lim, Eugenie S.
    Shah, Shanty G.
    Waterhouse, Mona
    Akker, Scott
    Drake, William
    Plowman, Nick
    Berney, Daniel M.
    Richards, Polly
    Adams, Ashok
    Nowosinska, Ewa
    Brennan, Carmel
    Druce, Maralyn
    ENDOCRINE CONNECTIONS, 2019, 8 (05): : 571 - 578
  • [25] 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma
    Michel Toubeau
    Claude Touzery
    Alina Berriolo-Riedinger
    Alexandre Cochet
    François Brunotte
    Laurent Bedenne
    Jean-Pierre Cercueil
    Denis Krause
    European Journal of Nuclear Medicine, 2001, 28 : 669 - 670
  • [26] The usefulness of 131I SPECT/CT in patients with differentiated thyroid carcinoma (DTC)
    Spanu, A.
    Solinas, M. E.
    Chessa, F.
    Sanna, D.
    Nuvoli, S.
    Madeddu, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S224 - S224
  • [27] Effect of 131I treatment on parathyroid function in patients with differentiated thyroid carcinoma
    Xiao, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S586 - S587
  • [28] Pulmonary I-131 Radioiodine Clearance in Patients with Differentiated Thyroid Carcinoma.
    Selkinski, I.
    Happel, C.
    Middendorp, M.
    Plastowez, W.
    Sauter, B.
    Kranert, T.
    Gruenwald, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S427 - S427
  • [29] The evolving role of 131I for the treatment of differentiated thyroid carcinoma
    Robbins, RJ
    Schlumberger, MJ
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 : 28S - 37S
  • [30] Radiodine uptake in thyroid remnants in patients with differentiated thyroid cancer:: A comparison between very-low 131I diagnostic dose and high 131I therapy activities
    Azevedo-Silva, F.
    Cavaco, A.
    Freitas, D.
    Isidoro, J.
    Vieira, F.
    Costa, G.
    Pedroso-Lima, J.
    Ferrer-Antunes, A. I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S230 - S230